Abstract
The lungs are the most frequent metastatic site (75% of all cases) [3, 9] and are typical of renal cancer dissemination along the vena cava. Biologically it makes sense to render the lung free of the tumor to prevent its further spread. Local excision of metastases is an effective form of treatment in patients with underlying renal cell carcinoma if only one distant organ is affected; solitary lung metastases occur in l%–4% of all cases [14].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Atzpodien J, Körfer A, Franks CR, Pollwod AH, Kirchner H (1990) Home therapy with rIL2 and IFN-alpha-2b in advanced human malignancies. Lancet 335: 1509–1512
De Forges A, Rey A, Klink M, Ghosn M, Kramar A, Droz JP (1988) Prognostic factors of adult metastatic renal carcinoma: a multivariate analysis. Semin Surg Oncol 4: 149–154
De Kernion JB, Ramming KP, Smith RB (1978) The natural history of metastatic renal cell carcinoma: a computer analysis. J Urol 120: 148–152
Elson PJ, Witte RS, Trump DL (1988) Prognostic factors for survival in patients with recurrent or metastatic renal cell carcinoma. Cancer Res 48: 7310–7313
Jett JR, Hollinger CG, Zinsmeister AR, Pairolero PC (1983) Pulmonary resection of metastatic renal cell carcinoma. Chest 84: 442
Kaplan EL, Meier P (1958) Non-parametric estimation from incomplete observation. J Am Statistical Assoc 53: 457–481
Khoury S, Saul A (1986) Metastatic renal adenocarcinoma. In: De Kernion JB, Pavone-Maealuso M (eds) Tumors of the kidney. Williams and Wilkins, Baltimore, pp 194–294
Kim B, Louie AC (1992) Surgical resection following interleukin-2-therapy for metastatic renal cell carcinoma prolongs remission. Arch Surg 127: 1343–1349
Maldazys JG, De Kernion JB (1986) Prognostic factors in metastatic renal carcinoma. J Urol 136: 376–379
Mc Nichols DW, Segura JW, De Weerd JH (1981) Renal cell carcinoma. Long-term survival and late recurrence. J Urol 126: 17–23
Middleton RG (1967) Surgery for metastatic renal cell carcinoma. J Urol 97:973–979
Montie JE, Stewart BH, Straffon RA, Banowsky LHW, Hewitt CB, Montague DK (1977) The role of adjunctive nephrectomy in patients with metastatic renal cell carcinoma. J Urol 117: 376–379
Muss HB (1987) Interferon therapy for renal cell carcinoma. Semin Oncol 14: 36–42
O–Dea MJ, Zincke H, Utz DC, Bernatz BE (1978) The treatment of renal cell carcinoma with solitary metastasis. J Urol 120: 540–542
Palmer PA, Vinke J, Philip T, Negrier S, Atzpodien J, Kirchner H, Oskam R, Franks CR (1992) Prognostic factors for survival in patients with advanced renal cell carcinoma treated with recombinant interleukin-2. Ann Oncol 3: 475–480
Peto R, Peto J (1972) Asymptomatically efficient rank invariant test procedures. J R Statistical Soc A 135: 185–206
Pomer S, Thiele R, Daniel V, Weimer R, Löhrke H, Schirrmacher V, Staehler G (1991) Sequential treatment of patients with advanced renal cell carcinoma with autologous tumor vaccine and subcutanous administration of recombinant interleukin 2 and interferon alpha-2b. World J Urol 9: 223–227
Rosenberg SA, Lotze MT, Mule J J (1988) New approaches to the immunotherapy of cancer using interleukin-2. Ann Intern Med 108: 853–864
Rosenberg SA, Lotze MT, Yang JC (1989) Combination therapy with IL-2 and IFN-alpha for the treatment of patients with advanced cancer. J Clin Oncol 7: 1726–1732
Vogt-Moykopf I, Meyer G (1986) Surgical technique in operations for pulmonary metastases. J Thorac Cardio vase Surg 34: 125–132
West WH, Tauer KN, Yannelli JR (1987) Constant-infusion rIL2 in adoptive immunotherapy of advanced cancer. N Engl J Med 316: 898–905
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Branscheid, D., Pomer, S., Krysa, S., Vogt-Moykopf, I. (1994). Survival After Lung Surgery for Metastatic Renal Cancer. In: Staehler, G., Pomer, S. (eds) Contemporary Research on Renal Cell Carcinoma. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-78609-9_4
Download citation
DOI: https://doi.org/10.1007/978-3-642-78609-9_4
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-78611-2
Online ISBN: 978-3-642-78609-9
eBook Packages: Springer Book Archive